These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18754806)

  • 21. Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere University Hospital: a case-control study, Finland October 2002 to January 2010.
    Rahikka P; Syrjänen J; Vuento R; Laine J; Huttunen R
    Euro Surveill; 2011 Sep; 16(35):. PubMed ID: 21903040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
    J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance.
    Groome MJ; Albrich WC; Wadula J; Khoosal M; Madhi SA
    Paediatr Int Child Health; 2012 Aug; 32(3):140-6. PubMed ID: 22824661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons.
    Crum-Cianflone NF; Burgi AA; Hale BR
    Int J STD AIDS; 2007 Aug; 18(8):521-6. PubMed ID: 17686212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
    Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature.
    Shadyab AH; Crum-Cianflone NF
    HIV Med; 2012 Jul; 13(6):319-32. PubMed ID: 22276696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ?
    Abernethy J; Sharland M; Johnson AP; Hope R
    J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults.
    Mathews WC; Caperna JC; Barber RE; Torriani FJ; Miller LG; May S; McCutchan JA
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):155-60. PubMed ID: 16186732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
    Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.
    Lin SH; Liao WH; Lai CC; Liao CH; Tan CK; Wang CY; Huang YT; Hsueh PR
    J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Marchaim D; Kaye KS; Fowler VG; Anderson DJ; Chawla V; Golan Y; Karchmer AW; Carmeli Y
    Clin Microbiol Infect; 2010 Jun; 16(6):747-52. PubMed ID: 19723135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
    Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
    Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia.
    Sit PS; Teh CS; Idris N; Sam IC; Syed Omar SF; Sulaiman H; Thong KL; Kamarulzaman A; Ponnampalavanar S
    BMC Infect Dis; 2017 Apr; 17(1):274. PubMed ID: 28407796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
    Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
    J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
    Cuervo G; Camoez M; Shaw E; Dominguez MÁ; Gasch O; Padilla B; Pintado V; Almirante B; Molina J; López-Medrano F; Ruiz de Gopegui E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MÁ; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    BMC Infect Dis; 2015 Oct; 15():484. PubMed ID: 26518487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital.
    Tumbarello M; Tacconelli E; Caponera S; Cauda R; Ortona L
    J Infect; 1995 Sep; 31(2):123-31. PubMed ID: 8666842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.